An antidiabetic thiazolidinedione (TDZ) drug with anti-inflammatory and anti-tumor activities. A potent and selective PPARɣ agonist. The EC₅₀ values for transactivation of human and murine PPARɣ in a cell-based assay are 0.55 and 0.78 µM, respectively.